Here are five insights:
1. Orthofix reported earnings per share guidance of $1.54 to $1.63.
2. The company’s revenue guidance is $428 million to $431 million.
3. Orthofix’s stock carries a market capitalization of $976.27 million.
4. The company’s stock has a P/E ratio of $125.83.
5. The 50-day moving average price is $49.01 and the 200-day moving average is $45.60.
More articles on biologics:
Pinnacle Spine Group files for FDA clearance of InFill Lateral Fusion System: 4 points
Dr. Abba Zubair researches whether stem cells grow faster in space: 5 highlights
AngelMD’s venture capital fund supports bone biologic startup with 2nd investment: 6 takeaways
